Peptide analogs of insulin-like growth factor II
US5470828A · kind A · utility
66Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 1992 |
| Grant date | Nov 28, 1995 |
| Priority date | — |
| Expiry date | Sep 17, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides peptide analogues of insulin-like growth factor-1 (IGF-1) or factor-2 (IGF-2). The peptide analogues of IGF-1 have at least the glutamic acid residue at position 3 replaced by another amino acid. The peptide analogues of IGF-2 are replaced at position 5 or 6 with another amino acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.